J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea
· Delayed Price · Currency is KRW 10,790
+510 (4.96%)
At close: Jun 20, 2025, 3:30 PM KST
J2KBIO Revenue
J2KBIO had revenue of 7.27B KRW in the quarter ending March 31, 2025, a decrease of -6.93%. This brings the company's revenue in the last twelve months to 32.59B, up 5.64% year-over-year. In the year 2024, J2KBIO had annual revenue of 33.13B with 16.36% growth.
Revenue (ttm)
32.59B
Revenue Growth
+5.64%
P/S Ratio
1.79
Revenue / Employee
581.93M
Employees
56
Market Cap
58.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.13B | 4.66B | 16.36% |
| Dec 31, 2023 | 28.47B | 12.44B | 77.60% |
| Dec 31, 2022 | 16.03B | 1.81B | 12.75% |
| Dec 31, 2021 | 14.22B | 360.95M | 2.60% |
| Dec 31, 2020 | 13.86B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| Doosan Enerbility | 15.88T |
| Hanwha Aerospace | 15.28T |
| KB Financial Group | 14.93T |